Cardiovascular risks specificities in the women: how can we improve the management?

被引:2
作者
Mounier-Vehier, Claire [1 ]
Delsart, Pascal [1 ]
Letombe, Brigitte [2 ]
机构
[1] Univ Lille 2, Hop Cardiol, Serv Med Vasc & HTA, CHRU,Fac Med Henri Warembourg, F-59037 Lille, France
[2] Univ Lille 2, Serv Gynecol Pole Gynecol & Obstet, F-59037 Lille, France
来源
PRESSE MEDICALE | 2010年 / 39卷 / 02期
关键词
CORONARY-HEART-DISEASE; BLOOD-PRESSURE; HYPERTENSION; MENOPAUSE; MORTALITY; ADULTS; US;
D O I
10.1016/j.lpm.2009.10.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Some aspects of cardiovascular risk differ in women; on the whole, this risk is underestimated and insufficiently treated because of lack of knowledge of the problem. According to an INSERM report in 1999, one Frenchwoman in three will die from a cardiovascular disease, while only one in 25 will die of breast cancer. For new generations of women, the protective effect of the estrogen burden may be counterbalanced by the increasing prevalence during the perimenopausal period of metabolic syndrome, particularly harmful in terms of cardiovascular risk. Before oral contraceptives are prescribed, an extremely thorough history must be taken. These should in no case be prescribed for smokers older than 35 years, regardless of how little they smoke. Neither uncomplicated diabetes nor controlled dyslipidemia is a contraindication to hormonal contraception for women. It now seems clear that hormone therapy of menopause does not prevent cardiavascular disease. Nor, however, does it increase the risk if it is administered early, that is, during the first five years of menopause, and accompanied by Close monitoring of cardiovascular risk factors and annual reassessment of the benefit-risk balance. The old cliche remains true: the patient at high risk of cardiovascular disease is a man older than 50 years, who smokes and is obese. But men still die more often from cancer than from cardiovascular disease, while the latter is the leading of cause in women, especially after menopause. The symptoms are often misleading and diagnosis is thus frequently delayed. Smoking, lack of exercise, overweight, and stress are all risk factors in women of all ages, and exposure to them can increase as women grow older. These factors should alert the physician and induce earlier screening for cardiovascular disease. In practice, too many women and their physicians underestimate their real risk of cardiovascular accident. It is accordingly essential to develop new campaigns of information and prevention specifically for women.
引用
收藏
页码:234 / 241
页数:8
相关论文
共 50 条
  • [1] Preventing cardiovascular disease in women: how can we do better?
    Lindquist, Ruth
    Witt, Dawn R.
    Boucher, Jackie L.
    CURRENT OPINION IN CARDIOLOGY, 2012, 27 (05) : 542 - 549
  • [2] How Can We Improve the Management of Patients with Hypertension?
    Alpert, Joseph S.
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (01) : 1 - 2
  • [3] How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
    Laverty, H. G.
    Benson, C.
    Cartwright, E. J.
    Cross, M. J.
    Garland, C.
    Hammond, T.
    Holloway, C.
    McMahon, N.
    Milligan, J.
    Park, B. K.
    Pirmohamed, M.
    Pollard, C.
    Radford, J.
    Roome, N.
    Sager, P.
    Singh, S.
    Suter, T.
    Suter, W.
    Trafford, A.
    Volders, P. G. A.
    Wallis, R.
    Weaver, R.
    York, M.
    Valentin, J. P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (04) : 675 - 693
  • [4] Cardiovascular risk: can we improve it in dialysis patients?
    Hummel, A.
    Rossignol, P.
    Rieu, P.
    Fouque, D.
    NEPHROLOGIE & THERAPEUTIQUE, 2013, 9 : 6 - 11
  • [5] From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?
    Sessa, Anna
    Allaire, Manon
    Lebray, Pascal
    Medmoun, Mourad
    Tiritilli, Alberto
    Iaria, Pierre
    Cadranel, Jean-Francois
    JHEP REPORTS, 2021, 3 (02)
  • [6] Cardiovascular mortality: how can it be prevented?
    Estruch, Ramon
    NEFROLOGIA, 2014, 34 (05): : 561 - 569
  • [7] Preeclampsia and future cardiovascular disease in women: How good are the data and how can we manage our patients?
    Seely, Ellen W.
    Tsigas, Eleni
    Rich-Edwards, Janet W.
    SEMINARS IN PERINATOLOGY, 2015, 39 (04) : 276 - 283
  • [8] Colorectal carcinoma - How can we improve prevention?
    Wilhelmi, Martin
    Burkhart, Andreas
    Netzer, Peter
    THERAPEUTISCHE UMSCHAU, 2021, 78 (02) : 61 - 72
  • [9] Can We Improve Adherence to Preventive Therapies for Cardiovascular Health?
    Ockene, Judith K.
    Schneider, Kristin L.
    Lemon, Stephenie C.
    Ockene, Ira S.
    CIRCULATION, 2011, 124 (11) : 1276 - 1282
  • [10] Comorbidity in young patients with juvenile systemic lupus erythematosus: how can we improve management?
    Ciurtin, Coziana
    Robinson, George A.
    Pineda-Torra, Ines
    Jury, Elizabeth C.
    CLINICAL RHEUMATOLOGY, 2022, 41 (04) : 961 - 964